Clinical trial
A Double Blind, Placebo Controlled, Dose Escalation Trial of Glycerol Phenylbutyrate Corrector Therapy for Cystic Fibrosis
NCT02323100 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind, Placebo Controlled, Dose Escalation Trial of Glycerol Phenylbutyrate Corrector Therapy for Cystic Fibrosis
- Lead sponsor
- National Jewish Health
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- December 2, 2018
- Completion date
- March 1, 2022
- Enrollment
- 16 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.